Practical efficacy of olmesartan vs. azilsartan in patients with hypertension: MUSCAT-4 study |
Molecule Updates
eMediNexus Coverage from: 
Practical efficacy of olmesartan vs. azilsartan in patients with hypertension: MUSCAT-4 study
eMediNexus,  26 February 2018
Coronavirus Live Count Map India

remove_red_eye 3962 Views
COVID-19 Vaccine Updates


#Cardiology #Nephrology

12 Read Comments                

A randomized-controlled trial compared the practical efficacy of olmesartan with azilsartan in 84 patients treated with conventional ARBs for more than 3 months. These patients were randomly allocated to receive either 20 mg of olmesartan (olmesartan medoxomil, OL group) or 20 mg of azilsartan (azilsartan, AZ group) OD for 16 weeks. The practical efficacy on blood pressure (BP) was compared between the two groups.Office BP decreased significantly in both the groups (OL group: 152/8...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now